Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 26, 2025	Sep. 27, 2024
Cash flows from operating activities:
Net earnings	$ 2,417	$ 2,813
Noncash items:
Depreciation	555	534
Amortization of intangible assets	1,269	1,223
Amortization of acquisition-related inventory fair value step-up	0	25
Stock-based compensation expense	235	231
Investment losses and pretax gain on sale of product line	140	(7)
Impairment charges	548	222
Change in trade accounts receivable, net	(65)	482
Change in inventories	(242)	(117)
Change in trade accounts payable	(134)	(186)
Change in prepaid expenses and other assets	(53)	299
Change in accrued expenses and other liabilities	(371)	(850)
Net cash provided by operating activities	4,299	4,669
Cash flows from investing activities:
Cash paid for acquisitions	0	(525)
Payments for additions to property, plant and equipment	(785)	(876)
Proceeds from sales of property, plant and equipment	10	12
Payments for purchases of investments	(79)	(188)
Proceeds from sales of investments	12	251
Proceeds from sale of product line	9	0
All other investing activities	21	39
Total cash used in investing activities	(812)	(1,287)
Cash flows from financing activities:
Proceeds from the issuance of common stock in connection with stock-based compensation, net	39	143
Payment of dividends	(652)	(573)
Net proceeds from borrowings (maturities of 90 days or less)	22	1
Borrowings (maturities longer than 90 days)	4	0
Repayments of borrowings (maturities longer than 90 days)	(500)	(974)
Payments for repurchase of common stock	(3,088)	(5,170)
All other financing activities	(108)	(120)
Total cash used in financing activities	(4,283)	(6,693)
Effect of exchange rate changes on cash and equivalents	246	74
Net change in cash and equivalents	(550)	(3,237)
Beginning balance of cash and equivalents	2,078	5,864
Ending balance of cash and equivalents	1,528	2,627
Supplemental disclosures:
Cash interest payments	231	280
Cash income tax payments	$ 808	$ 933